To view the PDF file, sign up for a MySharenet subscription.

DSY - Discovery Holdings Limited - Abridged pre-listing statement

Release Date: 02/08/2011 12:00
Code(s): DSY
Wrap Text

DSY - Discovery Holdings Limited - Abridged pre-listing statement Discovery Holdings Limited (Incorporated in the Republic of South Africa) (Registration number: 1999/007789/06) ISIN: ZAE000022331 Share Code: DSY ("Discovery" or "the Company") ABRIDGED PRE-LISTING STATEMENT Prepared in terms of the Listings Requirements of the JSE Limited ("JSE") relating to the listing of the non-cumulative, non-participating, non- convertible, voluntarily redeemable no par value preference shares in the share capital of Discovery ("B Preference Shares") on the JSE with effect from the commencement of business on or about Monday 15 August 2011. Discovery issued a Pre-listing Statement today, Tuesday 2 August 2011, relating to listing of the B Preference Shares under the "Specialist Securities - Preference Shares" sector of the JSE. The information in this abridged Pre-listing Statement has been extracted from the Pre- listing Statement. 1. Introduction and rationale Discovery actively manages its capital base in order to enhance shareholder value through its capital management framework. On 2 August 2011, at a general meeting of Discovery shareholders, various resolutions were proposed and passed, including, inter alia, the resolutions to create the B Preference Shares and place the B Preference Shares under the directors` control (as required by Discovery`s memorandum of incorporation ("MOI")). Discovery intends to issue B Preference Shares in terms of an offer for subscription by way of a private placement. Proceeds from the issue are intended to provide additional capital to support the continued growth of Discovery`s existing businesses, enhance Discovery`s ability to take advantage of future growth opportunities and aide Discovery in further diversifying its funding structure and strengthening its regulatory capital base. 2. Information relating to Discovery Discovery is a leading financial services institution founded on the principles of consumer engagement, product innovation and product integration. Discovery is incorporated in South Africa and was first listed on the JSE in 1999. The Discovery Group operates across a number of markets including health insurance, life assurance, long term savings, financial services, wellness, and most recently, short term insurance. Discovery is domiciled in South Africa, but has operations in the United Kingdom, the United States and China, as follows: 2.1 Consumer-engaged health insurance Discovery offers health insurance products through Discovery Health in South Africa, PruHealth in the United Kingdom and Ping An Health in China. Discovery Health, a wholly-owned subsidiary, provides administration services and managed care services to over 2.5 million lives and 14 medical schemes. PruHealth Discovery`s health insurance joint venture with Prudential plc, offers policyholders in the United Kingdom consumer-directed products linked to the Vitality wellness programme and provides cover for a range of private healthcare related claims. In August 2010, Discovery increased its shareholding in the joint venture from 50% to 75% through the acquisition of Standard Life HealthCare. Following the acquisition PruHealth covers around 650,000 lives. In November 2010 Discovery acquired a 20% stake in Ping An Health, Discovery`s health insurance joint venture with the Ping An Group of China, The joint venture will draw on Discovery`s extensive health product intellectual property and risk management structures and expertise, and the Ping An Group`s comprehensive distribution network infrastructure and brand in the Chinese market. 2.2. Consumer-engaged life assurance In South Africa, Discovery offers life assurance products through Discovery Life, a wholly-owned subsidiary. Discovery Life offers a range of insurance and financial solutions to both individual and group policyholders. The Discovery Life products reflect Discovery`s underlying philosophy to make members healthier and to enhance and protect their lives, and offer some unique benefits that integrate with the benefits offered by Discovery Health, Vitality and Discovery Invest. Discovery has a 75% share in PruProtect, Discovery`s life insurance joint venture with Prudential plc in the United Kingdom. PruProtect products sells pure protection products which are based on the Vitality structure that enables dynamic pricing to be employed in the UK life assurance market. 2.3. Investment and long-term savings Discovery Invest, a wholly-owned subsidiary operates in the long-term savings and investment market in South Africa. Discovery Invest was launch at the end of 2007 and to date has attracted over R16.5 billion in assets under management. 2.4. Wellness and health Vitality, Discovery`s wellness programme operates in South Africa, the United Kingdom and the United States. Vitality, a science-based wellness programme, has more than 1.6 million members worldwide. Through a range of health and lifestyle benefits, Vitality encourages its members to engage in healthy behaviours that have proven to reduce long-term healthcare costs. 2.5. Short term insurance Discovery recently launched Discovery Insure, a short-term insurance company which aims to unlock value for consumers in the South African short-term insurance market. Through Discovery Insure, the Group aims to leverage the behavioural expertise developed in Vitality with the latest motor telematics technology to create an incentive-based short term insurer. 2.6. Financial services The DiscoveryCard, which is offered to Discovery clients in South Africa, integrates with the Vitality programme to reward members for healthy behaviour. 3. Directors The full names, ages, nationalities (if not South African), addresses, occupations and profiles of the directors are set out below: Executive directors
Adrian Gore (47) Group Chief Executive Officer (Appointed to the board on 17/9/1999) Business address: 155 West Street, Sandton, 2146 BSc (Hons), FFA, ASA, MAAA, FASSA Adrian founded Discovery in 1992 after conceiving the idea of a specialist risk management company offering clients innovation, flexibility, value and service. He is the group chief executive officer. Richard Farber (40) Group Financial Director (Appointed to the board on 1/7/2009) Business address: 155 West Street, Sandton, 2146 BCom (Hons), CA (SA), FCMA Richard was the group accountant at Investec Bank before joining Discovery in 2003 as chief financial officer. He joined the Discovery Board as financial director on 1 July 2009.
Hylton D Kallner (36) Chief Marketing Officer (Appointed to the board on 3/6/2010) Business address: 155 West Street, Sandton, 2146 BEconSc, FFA, FASSA Hylton is the chief marketing officer for the Discovery Group. He graduated from the University of Witwatersrand with a degree in actuarial science. Since he joined Discovery in 1996, he has held several positions in actuarial and strategic projects as well as marketing. Neville S Koopowitz (47)Chief Executive Officer of PruHealth (Appointed to the board on 17/9/1999) Business address: Marble Arch Tower, 7th Floor, 55 Bryanston Street, London, W1H7AA BCom, CFP Neville joined Discovery as Marketing Director in 1996, playing a defining role in the evolution of the Discovery brand. He is the chief executive officer of PruHealth.
Herschel P Mayers (51) Chief Executive Officer of Discovery Life, Discovery Invest and PruProtect (Appointed to the board on 1/3/2000) Business address: 155 West Street, Sandton, 2146 BSc (Hons), FIA, FASSA Herschel held senior positions at Liberty Life before joining Discovery to co-found Discovery Life in 2000. He is the chief executive officer of Discovery Life, Discovery Invest and PruProtect. Dr Ayanda Ntsaluba (51) Executive Director (Appointed to the board on 1/7/2011) Business address: 155 West Street, Sandton, 2146 MBchB,FCOG(SA), MSc (HPPF), Exec MBA Ayanda is a qualified Obstetrician and Gynaecologist, with an MSc in Health Policy Planning and Financing from the University of London, an Executive MBA from the University of Cape Town. Prior to joining Discovery, Ayanda most recently served as the Director General of the Department of International Relations and Co-operation (formerly Foreign Affairs) of the Republic of South Africa, and prior to that, as Director General of the Department of Health.
Alan Pollard (42) Chief Executive Officer of Vitality (Appointed to the board on 30/8/2007) Business address: 155 West Street, Sandton, 2146 BSc (Hons), FIA, FSSA Alan, an actuary, joined Discovery in 1994. He headed up research and product development at Discovery Health before taking on his current role as chief executive officer of Discovery Vitality. John M Robertson (62) Group Chief Information Officer (Appointed to the board on 17/9/1999) Business address: 155 West Street, Sandton, 2146 BCom, CTA, CA (SA), HDip Tax After a career in IT consulting, John joined Discovery at its inception to develop its IT strategy, systems and finance infrastructure. He is group chief information officer; also responsible for group risk and compliance.
Barry Swartzberg (46) Executive Director (Appointed to the board on 3/8/1999) Business address: 155 West Street, Sandton, 2146 BSc, FFA, ASA, FASSA, CFP Barry is one of Discovery`s founders and contributed to the evolution of the group`s marketing approach, risk management capability and operations. He is currently group executive director, responsible for international operations. Non-executive directors
Monty I Hilkowitz (Chairperson) (70) Non-executive director (Appointed to the board on 11/4/2002) Business address: 155 West Street, Sandton, 2146 FIA Monty`s career has spanned investment management, financial services and insurance interests in several countries. He is currently self-employed and holds directorships with two leading financial services companies. Dr Brian A Brink (59) Non-executive director (Appointed to the board on 19/2/2004) Business address: 45 Main Street, Johannesburg, 2001 BSc (Med), MBBCh, DA (SA) Brian is a respected thought-leader in the health arena, with particular interests in health systems strengthening, HIV/AIDS and TB management and women`s health issues. He is the chief medical officer at Anglo American. Peter Cooper (55) Non-executive director (Appointed to the board on 1/1/2008) Business address: 3rd Floor, Great Westerford, Main Road, Newlands, Cape Town, 7700 BCom (Hons), HDip Tax, CA (SA) Peter is the chief executive officer of RMB Holdings Limited and Rand Merchant Insurance Holdings Limited, both of which are listed on the JSE. He has more than 30 years of experience in corporate and structured finance in South Africa. Steven B Epstein (68) (USA) Non-executive director (Appointed to the board on 17/2/2005) Business address: Epstein Becker & Green PC, 1227 25th Street, M+NW, Suite 700 Washington DC, DC 20037 JD (Columbia University Law School), BA (Tufts University) Steven is the founder and senior partner of one of the largest US-based health law firms and a champion of the concept that healthcare organisations need specialist legal representation.
Dr T Vincent Maphai (59) Non-executive director (Appointed to the board on 8/12/2005) Business address: 155 West Street, Sandton, 2146 BA, BA (Hons), M Phil, D Phil, Advanced Management Programme (Harvard) Vincent was formerly BHP Billiton`s chairperson, a research director at the HSRC and taught at universities locally and abroad. He is executive director of Corporate Affairs and Transformation at SAB Miller. Vhonani Mufamadi (42) Non-executive director (Appointed to the board on 3/6/2010) Business address: 155 West Street, Sandton, 2146 BA (Law), LLB Vhonani is the founder and chairperson of Muvoni Investment Holdings. After obtaining a BA Law and LLB degree from the University of Witwatersrand, he started his career as a consultant on human resources and management needs. Les Owen (62) (UK) Non-executive director (Appointed to the board on 6/12/2007) Business address: 155 West Street, Sandton, 2146 BSc (Hons), FIA, FPMI Les, a qualified actuary, has held top insurance positions in the UK and Australia. He brings to the Discovery board more than 30 years` experience of international insurance markets.
Sonja E Sebotsa (39) Non-executive director (Appointed to the board on 8/12/2005) Business address: 155 West Street, Sandton, 2146 LLB (Hons), MA Sonja is the founder and principal partner in Identity Partners, an investment firm, and has extensive expertise in corporate advisory work. She was previously a vice president in Deutsche Bank`s investment banking division. Tania Slabbert (44) Non-executive director (Appointed to the board on 1/1/2008) Business address: 155 West Street, Sandton, 2146 BA, MBA Tania is the chief executive officer of WDB Investment Holdings, and uses her investment expertise to facilitate the socio-political and economic development of women in South Africa.
Sindi V Zilwa (44) Non-executive director (Appointed to the board on 20/2/2003) Business address: 155 West Street, Sandton, 2146 BCompt (Hons), CTA, CA (SA), Advanced Taxation Certificate, CFP, Advanced Diploma in Financial Planning, Advanced Diploma in Banking Sindi is the chief executive officer of Nkonki, a chartered accountancy firm. She is a thought-leader in the areas of business, entrepreneurship and transformation. 4. Share capital of Discovery 4.1. Authorised and issued share capital before the offer for subscription: Authorised shares 1,000,000,000 ordinary shares of 0,1 cent 1,000 per share (R`000)
40,000,000 A Preference Shares (R`000) ( )* 20,000,000 B Preference Shares (R`000) 2,000,000 20,000,000 C Preference Shares (R`000) ( )*
Issued shares 591 872 390 ordinary shares of 0,1 cent 592 per share (R`000) Share premium (R`mn) 1,577.4
* Value of share capital to be determined in accordance with each relevant A Preference Share and C Preference Share resolution passed by the directors of Discovery, as may be applicable. 4.2. Authorised and issued share capital after the offer for subscription: The table below is for illustrative purposes only and sets out the authorised and issued capital of Discovery (assuming a total subscription of R400 million): Authorised shares 1,000,000,000 ordinary shares of 0,1 cent 1,000 per share (R`000) 40,000,000 A Preference Shares (R`000) ( )* 20,000,000 B Preference Shares (R`000) 2,000,000 20,000,000 C Preference Shares (R`000) ( )* Issued shares 591 872 390 ordinary shares of 0,1 cent 592 per share (R`000) Share premium (R`mn) 1,577.4 4,000,000 B Preference Shares (R`mn) 400 * Value of share capital to be determined in accordance with each relevant A Preference Share and C Preference Share resolution passed by the directors of Discovery, as may be applicable. At the general meeting of Discovery shareholders on 2 August 2011, an ordinary resolution was passed to place all of the unissued B Preference Shares under the control of the directors so that the B Preference Shares may be issued over a period of 36 months. 5. Details of the offer for subscription by way of a private placement Subject to the fulfilment of the conditions listed in paragraph 5.3 below, application will be made to the JSE on the closing date of the offer for subscription to list the B Preference Shares in the "Specialist Securities - Preference Shares" sector under the abbreviated name "DSY B PREF", with alpha code "DSBP" and ISIN number ZAE000158564, with effect from the commencement of business on or about Monday, 15 August 2011. The number of B Preference Shares to be listed will be determined on the closing date of the offer for subscription. 5.1. Salient terms of the B Preference Shares Deemed issue price for dividend R100 calculation purposes Preference dividend rate on issue 85% of the prime rate of South Africa ("Prime Rate")
Minimum Rand value of subscription per R1 million applicant who is a single addressee acting as principal Minimum Rand value of subscription per No minimum applicant who is a person named in section 96(1)(a) of the Companies Act, No. 71 of 2008 (as amended or replaced) Minimum amount to be raised in terms of R250 million the offer for subscription 5.2. Times and dates of the opening and closing of the offer for subscription Opening date of the offer for subscription Tuesday, 2 (12:00) August 2011 Closing date of the offer for subscription Monday, 8 (16:00) August 2011 Proposed listing date (09:00) Monday, 15 August 2011 Any changes to these dates and times will be released on SENS and published in the press. Applications to subscribe for B Preference Shares in terms of the offer for subscription must be made in accordance with the application procedure set out in the Pre-listing Statement. Applicants applying for dematerialised B Preference Shares must inform their CSDP or broker of their application by the cut-off time stipulated by their CSDP or broker in terms of their agreement. 5.3. Conditions to the listing The listing of the B Preference Shares is subject to: - the requirements of the JSE in respect of the requisite spread of B Preference Shareholders, being a minimum of 50 public shareholders, being met; - the minimum subscription size being met; and - the filing with the Commission of the relevant resolution passed by Discovery shareholders at the general meeting held on 2 August 2011 to create the B Preference Shares. 5.4. Reservation of rights The directors reserve the right to accept or refuse any application(s), either in whole or in part or to abate any or all application(s) (whether or not received timeously) in such manner as they may, in their sole and absolute discretion, determine. The directors have the right to issue additional B Preference Shares by undertaking a separate private placement of B Preference Shares during or subsequent to this offer for subscription. The issue price may be negotiated between parties subject to the market conditions at the time. The distribution of this announcement in jurisdictions other than South Africa may be restricted by law, and persons into whose possession this announcement comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement may not be supplied to the public in any jurisdiction in which any registration, qualification or other requirements exist or would exist in respect of any public offering of shares. This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities other than the B Preference Shares by any person in any circumstances in which such offer or solicitation is unlawful and is not for distribution in or into Australia, Canada, Japan or the United States. 6. Salient features of the B Preference Shares The full terms of the B Preference Shares are set out in Annexure 3 of the Pre-listing Statement. The summary below is not conclusive or exhaustive, and potential investors should refer to Annexure 3 of the Pre- listing Statement for full particulars of the terms and conditions of the B Preference Shares. 6.1. Voting rights The holders of the B Preference Shares will only be entitled to vote during periods when a dividend in respect of a B Preference Share which has been declared or any part of it, remains in arrear and unpaid from the due date for payment thereof, any redemption amount which is due and payable is unpaid and / or when resolutions are proposed to amend the preferences, rights, limitations and other terms associated with such B Preference Shares. Should the B Preference Shareholders be entitled to vote at any meeting, then the voting rights attaching to the B Preference Shares shall be the lower of: i. that proportion of the total votes in the company which the aggregate deemed issue price (R100) ("Deemed Issue Price") of the B Preference Shares held by him bear to the aggregate amount of the share capital and/or stated capital of the company; and ii. that fraction per B Preference Share held by him such that the aggregate of all of the votes of all of the preference shares in the issued share capital of the company are less than 25% (twenty five per cent) of the aggregate of all votes held by all shareholders in the company entitled to vote at such meeting. 6.2. Entitlements to dividends The directors, at their discretion, may resolve to declare and pay in full or in part dividends on the B Preference Shares. If the directors do not resolve to pay such dividends, holders of the B Preference Shares will not have any right to receive any such dividends. Subject to the above, the holders of the B Preference Shares will receive a semi-annual dividend based on the dividend rate applicable to the B Preference Share (which shall be referenced to the Prime Rate) multiplied by the Deemed Issue Price, on a daily basis. The Deemed Issue Price for the purpose of calculating a dividend in respect of a B Preference Share shall be an amount of R100, notwithstanding the actual issue price of a B Preference Share. The directors have determined that the dividend rate applicable to the B Preference Shares at the time of the first issue of the B Preference Shares will be 85% of the Prime Rate. Dividends, if declared, are payable semi-annually on a date which is the earlier of not less than five business days prior to the date on which Discovery pays final and interim ordinary dividends to its ordinary shareholders, if applicable, and 90 calendar days after the applicable preference dividend accrual date. If dividends which have been declared are not paid within the abovementioned timeframe, they will be considered to be "unpaid" and shall accrue interest at the Prime Rate. The Company shall not be entitled to pay any dividend in respect of the Discovery ordinary shares if, in respect of the corresponding period to which such dividend relates, a dividend in respect of the B Preference Shares has not been paid. Following Part VIII of Chapter II of the South African Income Tax Act, 1962 (Act 58 of 1962), as amended ("the Income Tax Act") becoming effective (the "Dividends Tax Circumstances"), then the dividend rate applicable to the B Preference Shares will be increased in accordance with the following formula, namely: NDR = A/(1 - B) Where: NDR = the new dividend rate applicable to the B Preference Shares following the occurrence of the Dividends Tax Circumstances; A = the dividend rate prevailing immediately prior to the occurrence of the Dividends Tax Circumstances; B = the rate of dividends tax, it being recorded that it is currently anticipated that dividends tax will be levied at 10% (ten per cent). If there is any amendment to the Income Tax Act, other than as contemplated above, that results in the after tax return to the B Preference Shareholders on account of their holding of the B Preference Shares being reduced, provided such amendment to the Income Tax Act is uniformly applicable to all corporate tax payers and not only because of the particular circumstances of the company or any B Preference Shareholder, the dividend rate will be increased by the Company to the extent of the saving by the Company as a result of such amendments to the Income Tax Act. If such amendment to the Income Tax Act does not result in a saving by the Company, then, notwithstanding that such amendment may result in a reduction in the after tax returns of any B Preference Shareholders on account of its holding of B Preference Shares, then the dividend rate shall not be increased. The Company shall be entitled to require its auditors to verify whether it is obliged to increase the percentage of the dividend rate. 6.3. Ranking The B Preference Shares will rank behind any A Preference Shares, pari passu with the C Preference Shares and in priority to the Discovery ordinary shares with regard to dividends and repayment of capital on the winding-up of the Company. All the B Preference Shares form part of the same class of shares and all B Preference Shares for which listing will be applied, will rank pari passu in respect of all rights. Each B Preference Share shall confer upon the holder of the B Preference Share the right of a return of capital on the winding-up of the Company of an amount equal to the sum of: i. all unpaid dividends; ii. the redemption dividend as defined in article 53.1.20 of Discovery`s MOI; plus iii. the Deemed Issue Price (R100). 6.4. Regulatory redemption option In terms of a regulatory redemption option ("Regulatory Option"), Discovery may redeem all of the B Preference Shares within a reasonable period of time from which the board determines that there has been a change in the "Regulatory Capital Requirements" (defined below) as a result of which the B Preference Shares are, or will be, taken into account in determining the capital adequacy requirements and/or prudential standards applicable to the Discovery Group, differently to that applicable, or anticipated to be applicable as at date on which the resolutions of the shareholders in relation to the creation of the B Preference Shares were approved, provided that such change has an adverse impact in determining the capital adequacy requirements and/or prudential standards applicable to the Discovery Group. The Regulatory Capital Requirements are defined in Discovery`s MOI as all requirements, guidelines and policies from time to time of any regulatory authority having supervision over the Discovery Group, relating to such capital adequacy requirements and ratios and/or prudential standards, whether or not such requirements, guidelines or policies have the force of law (but if not having the force of law, which insurers in South Africa comply with customarily) and whether they are applied generally or specifically to the Discovery Group. Notice and payment under the Regulatory Option The Regulatory Option is subject to a notice period of not less than 15 days (or an extended notice period of up to 30 days). The notice is revocable. Any redemption in terms of the Regulatory Option is subject to the receipt of all applicable regulatory approvals if required. If Discovery exercises the Regulatory Option, each B Preference Share may be redeemed at the higher of: - the Deemed Issue Price (being R100); and - the market price (determined with reference to the "clean" 15 day VWAP of the B Preference Shares prior to the delivery by the Company of a notice exercising the Regulatory Option, plus: i. a premium in an amount equal to 2,5% (two comma five per cent) of the higher of the Deemed Issue Price and the market price; and ii. any applicable dividends, as determined in article 53.22 of Discovery`s MOI. 7. Copies of the Pre-listing Statement Copies of the Pre-listing Statement may be obtained during normal business hours from 12:00 on 2 August 2011 until the closing date of the offer for subscription from the Company, the Joint Book Runners and the Transfer Secretaries as detailed below: Discovery registered office: 155 West Street, Sandton, 2146 Investec Bank Limited: Andrew Middleton +27 11 291 6144 Rand Merchant Bank (A division of FirstRand Bank Limited): Daniella Keet +27 11 282 1272 Computershare Investor Services Proprietary Limited: 70 Marshall Street, Johannesburg, 2001 Sandton 2 August 2011 Lead Arranger, Joint Advisor, Joint Sponsor and Joint Book Runner Investec Bank Limited Joint Advisor, Joint Sponsor and Joint Book Runner RAND MERCHANT BANK (A division of FirstRand Bank Limited) Corporate law advisors Edward Nathan Sonnenbergs Inc. Date: 02/08/2011 12:00:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story